title: Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury.
abstract: To gain insight into the epigenetic regulation of CC-chemokine ligand (CCL) 2 and CCL3, key players in the peripheral sensitization leading to neuropathic pain, we examined the relationship between histone H3 modification and the upregulation of these molecules using a mouse model of neuropathic pain after partial sciatic nerve ligation (PSL). We found that circuiting bone marrow (BM)-derived macrophages infiltrated into the injured sciatic nerve (SCN) using enhanced green fluorescent protein chimeric mice. The mRNA levels of CCL2, CCL3 and their receptors (CCR2 and CCR1/CCR5, respectively) were increased in the injured SCN. Chromatin immunoprecipitation assay revealed that levels of lysine 9-acetylated histone H3 (H3K9Ac) and lysine 4-trimethylated H3 (H3K4me(3)) in the promoter regions of the CCL2 and CCL3 genes were increased in the injured SCN after PSL, indicating the enhancement of gene expression. Immunoreactivity for H3K9Ac and H3K4me(3) was localized in the nuclei of infiltrating BM-derived cells and CCL-expressing cells in the injured SCN. We observed H3K9Ac and H3K4me(3) mainly in the nuclei of recruited macrophages on day 7 after PSL. Furthermore, upregulation of CCLs and CCRs were suppressed by histone acetyltransferase inhibitor, anacardic acid. Taken together, our findings demonstrate that CCL2 and CCL3 are upregulated in the injured peripheral nerve through epigenetic histone modification in infiltrating immune cells such as macrophages. These chemokine cascades may subsequently elicit chronic neuroinflammation following nerve injury.
authors.affiliation: Department of Pharmacology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Japan.
authors.forename: Norikazu
authors.initials: N
authors.lastname: Kiguchi
authors.forename: Yuka
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Saika
authors.forename: Shiroh
authors.initials: S
authors.lastname: Kishioka
mesh_terms: D000107:Acetylation; D000818:Animals; D016026:Bone Marrow Transplantation / Q000379:methods; D018932:Chemokine CCL2 / Q000235:genetics* / Q000378:metabolism; D054405:Chemokine CCL3 / Q000235:genetics* / Q000378:metabolism; D044127:Epigenesis, Genetic; D006657:Histones / Q000378:metabolism*; D007150:Immunohistochemistry; D008239:Lysine / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D008745:Methylation; D051379:Mice; D008810:Mice, Inbred C57BL; D008813:Mice, Inbred ICR; D008822:Mice, Transgenic; D009437:Neuralgia / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D059348:Peripheral Nerve Injuries / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D054389:Receptors, CCR1 / Q000235:genetics / Q000378:metabolism; D054390:Receptors, CCR2 / Q000235:genetics / Q000378:metabolism; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012584:Sciatic Nerve / Q000293:injuries / Q000378:metabolism; D013997:Time Factors; D015854:Up-Regulation
chemical_list: C515301:Ccr1 protein, mouse; C515335:Ccr2 protein, mouse; D018932:Chemokine CCL2; D054405:Chemokine CCL3; D006657:Histones; D054389:Receptors, CCR1; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D008239:Lysine
keywords: Allodynia; Chemokine; Epigenetics; Macrophage; Neuropathic pain